Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Pharmacology and neuroimaging of antidepressant action.

Dunlop BW, Lecrubier Y, Fossati P.

Handb Clin Neurol. 2012;106:643-55. doi: 10.1016/B978-0-444-52002-9.00038-3. Review. No abstract available.

PMID:
22608649
2.

Commentary. Depression and antidepressant drugs.

Berger FM.

Clin Pharmacol Ther. 1975 Sep;18(3):241-8. Review. No abstract available.

PMID:
240528
3.

[Clinical pharmacology of antidepressant drugs].

Boissier JR.

Therapie. 1973 Mar-Apr;28(2):207-8. French. No abstract available.

PMID:
4766354
4.

Clinical pharmacology of imipramine and related antidepressant compounds.

Klerman GL, Cole JO.

Int J Psychiatry. 1967 Apr;3(4):267-304. Review. No abstract available.

PMID:
5342651
5.

Recognition and treatment of depression.

Corkery JC.

Am Fam Physician. 1987 Feb;35(2):197-200.

PMID:
3812172
6.

Mild depression in general practice: is the automatism of antidepressant prescribing an evidence-based approach?

Barbui C, Garattini S.

Acta Psychiatr Scand. 2006 Jun;113(6):449-51. No abstract available.

PMID:
16677220
7.

Standard and newly-available antidepressant drug treatments.

Lippmann S.

J Ky Med Assoc. 1983 Sep;81(9):687-92. No abstract available.

PMID:
6631183
8.

[Brain structures related to the mechanisms of depression and the mechanisms of action of antidepressive drugs].

Kostowski W, Płaźnik A.

Psychiatr Pol. 1987 Jul-Aug;21(4):317-25. Review. Polish. No abstract available.

PMID:
3327071
9.
10.

Inappropriate prescriptions of antidepressant drugs in patients with subthreshold to mild depression: time for the evidence to become practice.

Baumeister H.

J Affect Disord. 2012 Aug;139(3):240-3. doi: 10.1016/j.jad.2011.05.025. Epub 2011 Jun 8. Review.

PMID:
21652081
11.

Not as golden as standards should be: interpretation of the Hamilton Rating Scale for Depression.

Kriston L, von Wolff A.

J Affect Disord. 2011 Jan;128(1-2):175-7. doi: 10.1016/j.jad.2010.07.011. Epub 2010 Aug 8. Review.

PMID:
20696481
12.
13.

Optimising antidepressant use in clinical practice: towards criteria for antidepressant selection.

Mendlewicz J.

Br J Psychiatry Suppl. 2001 Sep;42:S1-3. Review.

PMID:
11532819
14.

Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients.

Montgomery SA.

Neuropharmacology. 1980 Dec;19(12):1185-90. Review. No abstract available.

PMID:
6449677
15.

[Changes in the bioelectric brain activity during treatment with antidepressive agents].

Stefanowa E.

Folia Med (Plovdiv). 1972;14(3):199-204. German. No abstract available.

PMID:
4631700
16.

Epilepsy, depression and antidepressant drugs.

Salzberg MR, Vajda FJ.

J Clin Neurosci. 2001 May;8(3):209-15. Review.

PMID:
11386793
17.

Zinc: the new antidepressant?

Levenson CW.

Nutr Rev. 2006 Jan;64(1):39-42. Review.

PMID:
16491668
18.

Prognostic prediction of therapeutic response in depression using high-field MR imaging.

Gong Q, Wu Q, Scarpazza C, Lui S, Jia Z, Marquand A, Huang X, McGuire P, Mechelli A.

Neuroimage. 2011 Apr 15;55(4):1497-503. doi: 10.1016/j.neuroimage.2010.11.079. Epub 2010 Dec 3.

PMID:
21134472
19.

The role of neurobiologic processes in treating depression.

Thase ME.

J Clin Psychiatry. 2010 Oct;71(10):e28. doi: 10.4088/JCP.9078tx4c.

PMID:
21062614
20.

Depression diagnosis and antidepressant treatment among depressed VA primary care patients.

Liu CF, Campbell DG, Chaney EF, Li YF, McDonell M, Fihn SD.

Adm Policy Ment Health. 2006 May;33(3):331-41.

PMID:
16755394

Supplemental Content

Support Center